MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Masimo Corporation ROCE Ratio 2011-2026 | MASI
Annual ROCE Ratio Masimo Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -25.35 | 10.0 | 15.68 | 18.17 | - | 18.07 | 20.63 | 23.69 | 25.63 | 23.47 | - | 23.8 | 29.87 | 44.25 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 44.25 | -25.35 | 18.99 |
Quarterly ROCE Ratio Masimo Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.36 | 19.65 | 16.52 | 9.56 | 11.8 | 11.43 | 11.23 | 10.88 | 12.72 | 12.31 | 13.23 | 10.22 | 14.83 | 17.67 | 18.84 | 18.45 | 18.06 | 18.01 | 14.35 | 19.62 | 19.83 | 19.65 | 18.94 | 19.23 | 19.83 | 20.71 | 21.47 | 22.08 | 23.01 | 23.74 | 25.38 | 74.61 | 75.2 | 75.64 | 75.11 | 30.37 | 34.29 | 37.6 | 39.39 | 36.6 | 34.01 | 29.96 | 22.17 | 26.04 | 24.53 | 25.87 | 24.42 | 28.7 | 28.92 | 30.12 | 31.21 | 30.3 | 30.57 | 30.26 | 31.25 | 6.84 | 7.99 | 9.17 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 75.64 | 6.84 | 25.38 |
ROCE Ratio of other stocks in the Medical instruments industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
9.3 | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
0.2 | $ 19.92 | 0.94 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
5.75 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-131.33 | - | -9.52 % | $ 20.6 M | USA |
 |
Repro Med Systems
KRMD
|
-50.46 | $ 5.36 | -1.65 % | $ 244 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
9.12 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.55 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-3.75 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.0 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
17.41 | - | -0.02 % | $ 16.3 B | USA |
 |
OraSure Technologies
OSUR
|
-6.33 | $ 2.74 | -1.79 % | $ 204 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-82.32 | $ 8.65 | 3.1 % | $ 174 M | USA |
 |
Alcon
ALC
|
-2.56 | $ 80.83 | -0.37 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
-8.68 | $ 36.3 | -1.76 % | $ 1.7 B | USA |
 |
Haemonetics Corporation
HAE
|
27.02 | $ 65.68 | -0.42 % | $ 3.31 B | USA |
 |
electroCore
ECOR
|
-258.92 | $ 6.88 | -3.1 % | $ 37.9 K | USA |
 |
AngioDynamics
ANGO
|
-21.84 | $ 10.13 | 1.5 % | $ 414 M | USA |
 |
ICU Medical
ICUI
|
2.19 | $ 149.56 | -0.31 % | $ 3.65 B | USA |
 |
InfuSystem Holdings
INFU
|
3.45 | $ 8.1 | 0.56 % | $ 167 M | USA |
 |
STERIS plc
STE
|
13.12 | $ 260.7 | -0.36 % | $ 25.7 B | USA |
 |
The Cooper Companies
COO
|
8.29 | $ 80.7 | 0.41 % | $ 16.1 B | USA |
 |
Harvard Bioscience
HBIO
|
2.59 | $ 0.49 | -8.67 % | $ 20.8 M | USA |
 |
Glaukos Corporation
GKOS
|
-27.87 | $ 117.26 | -1.52 % | $ 5.68 B | USA |
 |
Merit Medical Systems
MMSI
|
11.29 | $ 80.09 | -0.19 % | $ 4.66 B | USA |
 |
Isoray
ISR
|
-31.27 | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
-127.06 | $ 148.9 | -0.06 % | $ 4.65 B | USA |
 |
LeMaitre Vascular
LMAT
|
15.49 | $ 84.46 | 0.72 % | $ 1.9 B | USA |
 |
Intuitive Surgical
ISRG
|
14.29 | $ 503.83 | -0.73 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
-61.36 | - | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
13.08 | $ 60.61 | -1.69 % | $ 220 M | USA |
 |
Microbot Medical
MBOT
|
-218.95 | $ 1.82 | -2.15 % | $ 18.6 M |  Israel |
 |
Nephros
NEPH
|
-19.06 | $ 4.4 | 0.23 % | $ 45.7 M | USA |
 |
Milestone Scientific
MLSS
|
-115.85 | $ 0.3 | -1.38 % | $ 23.9 M | USA |
 |
Envista Holdings Corporation
NVST
|
-35.38 | $ 23.08 | -1.33 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
22.96 | $ 37.95 | -3.69 % | $ 125 M | USA |
 |
Predictive Oncology
POAI
|
5399.27 | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
-98.23 | $ 13.88 | 1.91 % | $ 667 M | USA |
 |
Becton, Dickinson and Company
BDX
|
10.16 | $ 201.3 | 0.11 % | $ 57.9 B | USA |
 |
Repligen Corporation
RGEN
|
1.79 | $ 152.02 | -2.78 % | $ 8.47 M | USA |
 |
ResMed
RMD
|
22.7 | $ 250.46 | -2.78 % | $ 36.6 B | USA |
 |
BioLife Solutions
BLFS
|
-2.04 | $ 21.94 | -2.85 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
-133.63 | $ 2.24 | -3.86 % | $ 181 M | USA |
 |
Retractable Technologies
RVP
|
-24.21 | $ 0.69 | -2.01 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
-3.17 | $ 18.74 | -1.06 % | $ 921 M | USA |
 |
Teleflex Incorporated
TFX
|
3.53 | $ 105.09 | -0.37 % | $ 4.92 B | USA |
 |
West Pharmaceutical Services
WST
|
21.25 | $ 225.53 | -3.06 % | $ 16.5 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-45.26 | $ 12.32 | 0.37 % | $ 2.5 B | USA |